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The increasing demand of Insect Cell-Baculovirus Expression Vector System (IC-BEVS) based 
biopharmaceuticals raises the interest in developing high-titer production processes. Previously, 
we addressed the impact of the baculovirus infection on the physiology of High Five and Sf9 host 
cell lines, stressing out key cellular features that support higher productivities. This information 
was applied to design tailored supplementation schemes to boost IC-BEVS production yields of 
three targets with increasing complexity: recombinant influenza neuraminidase (rNeur); 
enveloped influenza VLPs (Inf-VLP) and the baculovirus itself (BV). Higher rNeur productivities 
were achieved when supplementing High Five cultures with cholesterol. For Sf9 cells, GSH, 
antioxidants combined with polyamines and cholesterol yielded the best outputs during Inf-VLPs 
and infectious BVs production. The results also show that the viral load influence the cellular 
responsiveness to the supplements, with lower MOIs retrieving higher improvements of IC-BEVS 
specific productivity. The careful selection of the MOI in a batch infection process, along with 
the supplementation of culture medium with compounds altering cellular redox state and 
cholesterol, yielded an improvement of the systems’ specific productivity up to 6 fold. The 
correlation between systems productivity, host cell line and target product was extensively 
analyzed. The resulting implications for the development of rational strategies for increased 
productivity are discussed.  
